Tissue Study on the Chronic Active Humoral Rejection (cAMR) Population of Kidney Transplantation

Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Study ID
NCT06794970
Status
Recruiting
Apply to this trial

Conditions

  • Kidney Transplant

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The study is tissue-based, retrospective and prospective, single-centre, non-sponsored. Primary objective: To examine patient and organ survival and eGFR variation in kidney transplant patients diagnosed histologically with cAMR.

Key Dates

First listed
Jan 27, 2025
Start date
May 1, 2023
Status verified
Dec 2024
Primary completion
Nov 1, 2028
Completion
Nov 1, 2028

Study Design

Enrollment
50 participants (estimated)

Primary Outcome Measure

Kidney survival post tranplant [ Time Frame: 1 year, 2 years ]

Central Contacts

Related Studies